Relevant bibliographies by topics / Drug development / Dissertations / Theses
To see the other types of publications on this topic, follow the link: Drug development.

Dissertations / Theses on the topic 'Drug development'

Author: Grafiati
Published: 4 June 2021
Last updated: 25 July 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 dissertations / theses for your research on the topic 'Drug development.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse dissertations / theses on a wide variety of disciplines and organise your bibliography correctly.

1

Zhang, Huarui. "Design, synthesis and activity evaluation of novel exosome inhibitors." HKBU Institutional Repository, 2020. https://repository.hkbu.edu.hk/etd_oa/849.

Full text
Abstract:
Background: Exosomes are extracellular vesicles (EVs) that produced in the endosomal compartment of most eukaryotic cells, and have observed increasing attentions over the past decades. They play important roles in cell- to-cell communications, they can carry varieties of substances, like proteins, nucleic acids and lipids, to the target cells they encounter. These cargos could influence the function of recipient cells. This novel mode of intercellular communication is found to be of critical importance to many cellular activities. However, exosomes are involved in various diseases processes.
APA, Harvard, Vancouver, ISO, and other styles
2

Larson, Joeanna Lee. "Perinatal Drug Abuse Intervention: Policy Development for Drug Screening." ScholarWorks, 2016. https://scholarworks.waldenu.edu/dissertations/2555.

Full text
Abstract:
Perinatal drug abuse is becoming a profound issue facing the health and wellbeing of neonates. The community serviced by the project site, which lies within the boundaries of an Indian Reservation, suffers from perinatal drug abuse at a higher rate than state and federal averages. The purpose of this project was to provide the project site with a policy to consistently screen for perinatal drug abuse. Lave's theory of situational learning and the Sanford Way model for quality improvement framed this project. To guide policy development, data were compiled through a systematic review of current
APA, Harvard, Vancouver, ISO, and other styles
3

Hartmann, Neil Godfried. "Intercalative drugs in cancer chemotherapy : two approaches towards drug development." Thesis, University of Cambridge, 1988. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.292983.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Mawad, Damia Graduate School of Biomedical Engineering Faculty of Engineering UNSW. "Development of Novel hydrogels for protein drug delivery." Awarded by:University of New South Wales. Graduate School of Biomedical Engineering, 2005. http://handle.unsw.edu.au/1959.4/25221.

Full text
Abstract:
Introduction: Embolic agents are used to block blood flow of hypervascular tumours, ultimately resulting in target tissue necrosis. However, this therapy is limited by the formation of new blood vessels within the tumour, a process known as angiogenesis. Targeting angiogenesis led to the discovery of anti-angiogenic factors, large molecular weight proteins that can block the angiogenic process. The aim of this research is development of poly (vinyl alcohol) (PVA) aqueous solutions that cross-link in situ to form a hydrogel that functions as an embolic agent for delivery of macromolecular drugs
APA, Harvard, Vancouver, ISO, and other styles
5

Fagnan, David Erik. "Analytics for financing drug development." Thesis, Massachusetts Institute of Technology, 2015. http://hdl.handle.net/1721.1/98572.

Full text
Abstract:
Thesis: Ph. D., Massachusetts Institute of Technology, Sloan School of Management, Operations Research Center, 2015.<br>This electronic version was submitted by the student author. The certified thesis is available in the Institute Archives and Special Collections.<br>Cataloged from student-submitted PDF version of thesis.<br>Includes bibliographical references (pages 133-139).<br>Financing drug development has a particular set of challenges including long development times, high chance of failure, significant market valuation uncertainty, and high costs of development. The earliest stages of
APA, Harvard, Vancouver, ISO, and other styles
6

Voyi, Kuku Vinolia Vuyelwa. "Development of an antirheumatic drug." Doctoral thesis, University of Cape Town, 1988. http://hdl.handle.net/11427/17187.

Full text
Abstract:
Includes bibliographical references.<br>The diamino-diamide ligands have been investigated in an attempt to develop an antirheumatic drug. The ligands N,N'-di-(2-dimethylamino)ethyloxamide and N,N'di-(2-diethylamino)ethyloxamide, were synthesised and characterised using the physical techniques, NMR, mass- and infrared spectrometry. The stability constants of the complexes of Mg, Ca, Zn and several first transition metal-ions with the ligands were determined potentiometrically. The solution conformation of the CuII complexes were determined using visible spectrophotometry. Finally the physico-c
APA, Harvard, Vancouver, ISO, and other styles
7

Alkhaldi, Abdulsalam Abdulhadi. "Drug development against kinetoplastid parasites." Thesis, University of Glasgow, 2012. http://theses.gla.ac.uk/3637/.

Full text
Abstract:
Human African trypanosomiasis and leishmaniasis are caused by parasites belonging to the genera Trypanosoma and Leishmania, respectively. Significant numbers of people are affected by these diseases worldwide, which are fatal if untreated. Animals can also be infected, posing agricultural and economic hindrances, especially in poor countries. Although chemotherapy can be used for treatment, many problems are associated with it, including drug toxicity, resistance, lack of guaranteed supply, and high treatment cost. Therefore, there is an urgent need for new treatment approaches. Here, we aim t
APA, Harvard, Vancouver, ISO, and other styles
8

Mavridis, Lazaros. "High throughput virtual drug screening using spherical harmonic molecular surface representations." Thesis, Available from the University of Aberdeen Library and Historic Collections Digital Resources, 2009. http://digitool.abdn.ac.uk:80/webclient/DeliveryManager?application=DIGITOOL-3&owner=resourcediscovery&custom_att_2=simple_viewer&pid=25936.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Wang, Shining. "DRUG DEVELOPMENT OF TARGETED ANTICANCER DRUGS BASED ON PK/PD INVESTIGATIONS." Diss., Temple University Libraries, 2008. http://cdm16002.contentdm.oclc.org/cdm/ref/collection/p245801coll10/id/2535.

Full text
Abstract:
Pharmaceutics<br>Ph.D.<br>EGFR inhibitors, such as gefitinib, are examples of targeted anticancer drugs whose drug sensitivity is related to gene mutations that adds a pharmacogenetic [PG] dimension to any pharmacokinetic [PK] and pharmacodynamic [PD] analysis. The goal of this project was to characterize the PK/PD properties of gefitinib in tumors and then apply these results to design rational drug design regimens, and provide a foundation for future studies with EGFR inhibitors. Progressions of in vitro and in vivo studies were completed to understand the PK and PD behavior of gefitinib. In
APA, Harvard, Vancouver, ISO, and other styles
10

Alavi, Hajar Karimi. "Development of mechanistic mathematical models for gene-mediated drug-drug interactions." Thesis, University of Manchester, 2016. https://www.research.manchester.ac.uk/portal/en/theses/development-of-mechanistic-mathematical-models-for-genemediated-drugdrug-interactions(b38da88a-bb2a-4667-9809-21a09c8feeeb).html.

Full text
Abstract:
The glucocorticoid receptor (GR) is a member of the nuclear hormone receptors family and has been shown to exert significant effects on the induction of cytochrome P450 (CYP) enzymes responsible for the metabolism of many xenobiotics. CYP3A4/5 and CYP2C9 are important CYP enzymes which metabolise more that 60% of drugs. Induction or inhibition of the enzymatic activity and the levels of these enzymes can have significant effects on drug metabolism. Understanding the role of GR and other nuclear receptors, pregnane X receptor (PXR) and the constitutive androstane receptor (CAR), in the mechanis
APA, Harvard, Vancouver, ISO, and other styles
11

Pavuluri, Nina. "Development and evaluation of drug-admicelle systems for poorly soluble drugs : a novel surfactant templated drug delivery platform /." Full text available from ProQuest UM Digital Dissertations, 2008. http://0-proquest.umi.com.umiss.lib.olemiss.edu/pqdweb?index=0&did=1781035201&SrchMode=1&sid=1&Fmt=2&VInst=PROD&VType=PQD&RQT=309&VName=PQD&TS=1258661510&clientId=22256.

Full text
Abstract:
Thesis (Ph.D.)--University of Mississippi, 2008.<br>Typescript. Vita. Major advisor: John O' Haver "June 2008." Includes bibliographical references (leaves 120-163). Also available online via ProQuest to authorized users.
APA, Harvard, Vancouver, ISO, and other styles
12

Strobeck, Matthew W. (Matthew William) 1972. "The drug development process : evaluation of PDUFA I/II and investigation into reducing drug development times." Thesis, Massachusetts Institute of Technology, 2004. http://hdl.handle.net/1721.1/28592.

Full text
Abstract:
Thesis (S.M.)--Harvard-MIT Division of Health Sciences and Technology; and, (S.M.)--Massachusetts Institute of Technology, Engineering Systems Division, Technology and Policy Program, 2004.<br>Includes bibliographical references (p. 59-61).<br>Published findings report that it takes approximately eight years to bring a novel drug to market at an average cost of $800 million. Over the last ten years, the Food and Drug Administration (FDA) has helped to reduce the time from filing a new drug application (NDA) to granting marketing approval (i.e. the approval phase). However, there has been no al
APA, Harvard, Vancouver, ISO, and other styles
13

Lee, Anna. "Bioinformatics approaches towards facilitating drug development." Thesis, McGill University, 2011. http://digitool.Library.McGill.CA:80/R/?func=dbin-jump-full&object_id=96984.

Full text
Abstract:
Drug development is currently a time-consuming, costly and challenging process. The process typically starts with the identification of a therapeutic target for a given disease. A therapeutic target is some biological molecule and the binding of compounds to target molecules is expected to cause a desired therapeutic effect. That is, target binding compounds have the potential to become drug candidates. However, there is a tendency for many drug candidates to fail during clinical trials, and consequently, very few candidates become approved new drugs. This trend suggests that the early stages
APA, Harvard, Vancouver, ISO, and other styles
14

郭心鈴 and Sum-ling Kwok. "New drug development in breast cancer." Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2008. http://hub.hku.hk/bib/B41710381.

Full text
APA, Harvard, Vancouver, ISO, and other styles
15

Thiers, Fabio Albuquerque. "The globalization of clinical drug development." Thesis, Massachusetts Institute of Technology, 2006. http://hdl.handle.net/1721.1/35556.

Full text
Abstract:
Thesis (S.M.)--Harvard-MIT Division of Health Sciences and Technology, 2006.<br>Includes bibliographical references (p. 54-58).<br>Industry-sponsored clinical research of investigational drugs (also called clinical development) has traditionally been carried out in relatively developed countries in the North American, Western European, and Pacific regions. However, lately it has been widely reported that clinical trials starting now are becoming increasingly diffused globally, with significant growth of activity in so-called emerging economies in Eastern Europe, Latin America, and Southeast As
APA, Harvard, Vancouver, ISO, and other styles
16

Kwok, Sum-ling. "New drug development in breast cancer." Click to view the E-thesis via HKUTO, 2008. http://sunzi.lib.hku.hk/hkuto/record/B41710381.

Full text
APA, Harvard, Vancouver, ISO, and other styles
17

Sanghvi, Tapan. "Formulation development of anticancer drug: FB642." Diss., The University of Arizona, 2004. http://hdl.handle.net/10150/289236.

Full text
Abstract:
Carbendazim (methyl-2-benzimidazolecarbamate), a well known anti-fungal agent that may have significant anti-cancer activity, is a poorly water-soluble ampholyte. Unfortunately its projected oral dose up to hundred mg per day is far greater than its water solubility of 6 μg/ml. The overall aim of this research was to conduct preformulation studies and develop therapeutically viable oral and parenteral formulations. The solubility of carbendazim was altered by using both solute and solvent modification approaches. The solvent modification was carried out by investigating the solubilization of c
APA, Harvard, Vancouver, ISO, and other styles
18

Cipriano, Sónia Domingues. "Pharmaceutical development: galenical development of a generic drug product." Master's thesis, Universidade de Aveiro, 2017. http://hdl.handle.net/10773/18818.

Full text
Abstract:
Mestrado em Biomedicina Farmacêutica<br>O desenvolvimento de genéricos reveste-se de grande complexidade pela demanda de qualidade associada a qualquer produto farmacêutico acrescida da complexa interpretação de situação jurídica (patentes), da seleção de um vasto número de moléculas e tecnologias que trarão um claro custo-benefício e dos exigentes prazos para as colocar em mercados, muitas vezes com diferentes requisitos regulatórios. Esta tese irá providenciar uma visão geral sobre um método standard numa indústria de desenvolvimento farmacêutico. O presente trabalho tem como objeti
APA, Harvard, Vancouver, ISO, and other styles
19

Alali, Khaled Y. A. A. "Development of National Drug Policy in the State of Kuwait." Thesis, University of Bradford, 2016. http://hdl.handle.net/10454/16793.

Full text
Abstract:
This Thesis examines the benefits and usefulness of a National Drug Policy (NDP) for the developing of the Health Care System in Kuwait. The NDP is one of the most important structures of the Health System which can lead to improved health services by establishing guidelines, proposals and directives to organize, structure and regulate health legislation; it is of help to ensure the availability of quality, safety and efficacy in using medicines and it can reduce the irrational use of medicines. The NDP is a frame work between the government, schools and universities, media, health professiona
APA, Harvard, Vancouver, ISO, and other styles
20

Sostelly, Alexandre. "Mechanistic model-based drug development in the management of anticancer drugs resistance." Thesis, Lyon 1, 2012. http://www.theses.fr/2012LYO10203.

Full text
Abstract:
La résistance aux chimiothérapies anticancéreuses constitue un problème majeur dans la prise en charge du cancer. Les transporteurs d'efflux contribuent à ce phénomène de résistance en altérant l'accumulation intracellulaire des cytotoxiques. Dans le passé, l'inhibition du transporteur d'efflux P-gp n'a pas permis de surmonter ce phénomène notamment à cause du manque de méthodes adéquates pour identifier et quantifier la pharmacologie des inhibiteurs d'efflux. Récemment de nouveaux inhibiteurs de BCRP, l'un des derniers transporteurs d'efflux découverts, ont été synthétisés permettant de retes
APA, Harvard, Vancouver, ISO, and other styles
21

Mohiddin, Syed Basha. "Development of novel unsupervised and supervised informatics methods for drug discovery applications." Columbus, Ohio : Ohio State University, 2006. http://rave.ohiolink.edu/etdc/view?acc%5Fnum=osu1138385657.

Full text
APA, Harvard, Vancouver, ISO, and other styles
22

Schreiber, Kimberly C. M. "Assay development for use in drug discovery against Bovine Trichomoniasis." Scholarly Commons, 2007. https://scholarlycommons.pacific.edu/uop_etds/650.

Full text
Abstract:
Bovine trichomoniasis is a venereal disease that affects cattle. The causative agent of this disease is Tritrichomonas foetus, a flagellated protozoan. There is no current FDA approved treatment for this disease. The purpose of this study was to develop new compound screening assays that will make the discovery of new compounds faster and more accurate. The CellTiter-Glo Luminescent Cell Viability Assay, a high throughput screening (HTS) assay from Promega, was found to be as affective at measuring cytotoxicity as traditional assaying techniques. For the first time. preen florescent protein. a
APA, Harvard, Vancouver, ISO, and other styles
23

Pieters, Toine. "Biology meets drug development the biography of a 'miracle' drug, the interferons /." [Maastricht : Maastricht : Universiteit Maastricht] ; University Library, Maastricht University [Host], 1999. http://arno.unimaas.nl/show.cgi?fid=6879.

Full text
APA, Harvard, Vancouver, ISO, and other styles
24

Patel, Fadheela. "Development of a cost-effective drug sensitivity test for multi-drug resistant and extensively drug-resistant tuberculosis." Thesis, Cape Peninsula University of Technology, 2010. http://hdl.handle.net/20.500.11838/1496.

Full text
Abstract:
Thesis (MTech (Biomedical Technology))--Cape Peninsula University of Technology, 2010<br>The World Health Organisation estimates that nine million people are infected with tuberculosis (TB) every year of which ninety-five percent live in developing countries. Africa has one of the highest incidences of TB in the world. but few of its countries are equipped to diagnose drug-resistant TB. This study aimed to develop a robust. yet simple and cost-effective assay. which would require minimal sophisticated instrumentation and specialised personnel that would make drug sensitivity screening for
APA, Harvard, Vancouver, ISO, and other styles
25

Chieng, Heng Liang Norman, and n/a. "Amorphous drug preparation using ball milling." University of Otago. School of Pharmacy, 2008. http://adt.otago.ac.nz./public/adt-NZDU20081209.162001.

Full text
Abstract:
Polymorphism and crystallinity are now recognised as important issues in drug development. This is shown by the increased amount of research in this area over recent years. In pharmaceutical development milling is an important unit operation for size reduction to improve powder handling, processing and dissolution rate. The aim of this thesis was to investigate the effect of ball milling (and cryo-milling) on the solid state properties, including amorphous drug formation, of pharmaceutical solids. Milling was carried out using an oscillatory ball mill (Mixer Mill MM301, Retsch GmbH & Co., Ge
APA, Harvard, Vancouver, ISO, and other styles
26

Garrett, Andrew. "The role of subgroups and sub-populations in drug development and drug regulation." Thesis, Open University, 2006. http://oro.open.ac.uk/54629/.

Full text
Abstract:
This thesis addresses the role of subgroups and sub-populations in drug development and regulation and includes the critical appraisal of regulatory guidance. Chapter One introduces clinical trial methodology and describes the current regulatory environment. In Chapter Two, randomisation is reviewed in relation to unbiased estimation of treatment differences and the impact of data exclusion to form subsets is described. Simpson's paradox (SP) is considered in Chapter Three. Randomisation is shown to protect against SP, while a treatment by factor interaction is not required. Balance is redefin
APA, Harvard, Vancouver, ISO, and other styles
27

Malm, Mikaela. "Drug Analysis : Bioanalytical Method Development and Validation." Doctoral thesis, Uppsala universitet, Analytisk kemi, 2008. http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-8547.

Full text
Abstract:
This thesis describes bioanalytical methods for drug determination in biological matrixes, with drugs in focus used against diseases largely affecting low-income countries. Solid-phase extraction is used for sample cleanup, and processed samples are analyzed by liquid chromatography. Developed bioanalytical methods are validated according to international guidelines. Eflornithine (DFMO) is a chiral drug, used for treating human African trypanosomiasis. A bioanalytical method for determination of DFMO enantiomers in plasma is presented. The enantiomers are detected by evaporative light-scatteri
APA, Harvard, Vancouver, ISO, and other styles
28

Andrée, Bengt. "Positron emission tomography in serotonergic drug development /." Stockholm, 2001. http://diss.kib.ki.se/2001/91-628-4779-1/.

Full text
APA, Harvard, Vancouver, ISO, and other styles
29

Rahman, Nargis Jahan. "Incorporation of population pharmacokinetics into drug development." Thesis, Imperial College London, 1999. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.325239.

Full text
APA, Harvard, Vancouver, ISO, and other styles
30

Goddard, Phylis Maud. "Clinically predictive models for platinum drug development." Thesis, Institute of Cancer Research (University Of London), 1998. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.287475.

Full text
APA, Harvard, Vancouver, ISO, and other styles
31

Rajapakse, Thiaga Anuradha. "Biopharmaceutical drug development modelling and portfolio management." Thesis, University College London (University of London), 2005. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.413689.

Full text
APA, Harvard, Vancouver, ISO, and other styles
32

Howe, Christopher D. (Christopher Dwight). "Financial model of the drug development process." Thesis, Massachusetts Institute of Technology, 1995. http://hdl.handle.net/1721.1/9832.

Full text
APA, Harvard, Vancouver, ISO, and other styles
33

Carroll, Kevin. "Statistical issues in oncologic clinical drug development." Thesis, University of East Anglia, 2013. https://ueaeprints.uea.ac.uk/47985/.

Full text
APA, Harvard, Vancouver, ISO, and other styles
34

Cai, Xiaoshu. "DEVELOPMENT OF COMPUTATIONAL APPROACH FOR DRUG DISCOVERY." Case Western Reserve University School of Graduate Studies / OhioLINK, 2016. http://rave.ohiolink.edu/etdc/view?acc_num=case1465403528.

Full text
APA, Harvard, Vancouver, ISO, and other styles
35

Senderoff, Richard I. "Development of fibrin-based drug delivery systems /." The Ohio State University, 1990. http://rave.ohiolink.edu/etdc/view?acc_num=osu1487677267728699.

Full text
APA, Harvard, Vancouver, ISO, and other styles
36

Cash, Devin R. "DRUG AND VACCINE DEVELOPMENT FOR NEISSERIA GONORRHOEAEA." VCU Scholars Compass, 2016. http://scholarscompass.vcu.edu/etd/4093.

Full text
Abstract:
Neisseria gonorrhoeae, the causative agent of the STI gonorrhea, is not preventable by vaccination and is rapidly developing resistance to antibiotics. One important strategy for gonococcal survival in the host is iron acquisition in the face of nutritional immunity. To overcome iron limitation, the gonococcus expresses TonB dependent transporters (TdTs), outer membrane proteins that facilitate nutrient acquisition. Of the TdTs, the transferrin (Tf), lactoferrin (Lf), and hemoglobin (Hb) receptors hijack iron directly from host proteins, and studies have already shown that the Tf receptor is e
APA, Harvard, Vancouver, ISO, and other styles
37

Hulín, Michal. "A drug development from risk management perspective." Master's thesis, Vysoká škola ekonomická v Praze, 2011. http://www.nusl.cz/ntk/nusl-124943.

Full text
Abstract:
The purpose of this diploma thesis is to understand financing of drug development from an enterprise risk management perspective as well as to critically assess the efficiency of the ISO framework and risk management techniques used for determining whether to fund drug development or not. The diploma thesis is divided into theoretical and practical part. The first part starts with perception and assessment of uncertainty and risk in the past. It describes how risk-averse individuals attempted to deal with uncertainty and different risk. This is followed by the evolution of traditional risk man
APA, Harvard, Vancouver, ISO, and other styles
38

Tran, Anh. "Development of new drug leads for tuberculosis." Thesis, The University of Sydney, 2014. http://hdl.handle.net/2123/11637.

Full text
Abstract:
Tuberculosis (TB), caused by infection with the bacterium Mycobacterium tuberculosis, has re-emerged as a global health risk with a significant proportion of new TB cases classified as multi-drug resistant (MDR) or extensively drug resistant (XDR). As such, there is a desperate need for the development of TB therapies which operate via novel modes of action. This thesis outlines the development of new drug leads for tuberculosis employing a target-based approach and by synthesis and derivatization of natural product scaffolds. Specifically, the first and second section of the thesis describes
APA, Harvard, Vancouver, ISO, and other styles
39

Kanzi, Aquillah Mumo. "Falcipains as malarial drug targets." Thesis, Rhodes University, 2013. http://hdl.handle.net/10962/d1003842.

Full text
Abstract:
Malaria is an infectious disease caused by parasites of the Plasmodium genus with mortality rates of more than a million annually, hence a major global public health concern. Plasmodium falciparum (P. falciparum) accounts for over 90% of malaria incidence. Increased resistance to antimalarial drugs by the Plasmodium parasite, coupled with the lack of an effective malaria vaccine necessitates the urgent need for new research avenues to develop novel and more potent antimalarial drugs. This study focused on falcipains, a group of P. falciparum cysteine proteases that belong to the clan CA and pa
APA, Harvard, Vancouver, ISO, and other styles
40

Ramsden, Justine. "Development of a TSM biosensor for the determination of DNA-drug interactions : a novel method to assist drug development." Thesis, De Montfort University, 2003. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.271708.

Full text
APA, Harvard, Vancouver, ISO, and other styles
41

Dahal, Gopal Prasad. "Development of Selective Inhibitors against Enzymes Involved in the Aspartate Biosynthetic Pathway for Antifungal Drug Development." University of Toledo / OhioLINK, 2018. http://rave.ohiolink.edu/etdc/view?acc_num=toledo1532889045486984.

Full text
APA, Harvard, Vancouver, ISO, and other styles
42

Schlipp, Katherine M. "Analytical method development a mathematical approach /." Electronic version (PDF), 2004. http://dl.uncw.edu/etd/2004/schlippk/katherinschlipp.pdf.

Full text
APA, Harvard, Vancouver, ISO, and other styles
43

Öhman, Daniel. "Bioanalytical development for application in therapeutic drug monitoring : focus on drugs used in psychiatry /." Linköping : Univ, 2003. http://www.bibl.liu.se/liupubl/disp/disp2003/med775s.pdf.

Full text
APA, Harvard, Vancouver, ISO, and other styles
44

Ghorpade, S. R. "Development of chemoenzymatic methods for the preparation of optically pure drugs and drug intermediates." Thesis(Ph.D.), CSIR-National Chemical Laboratory, Pune, 2001. http://dspace.ncl.res.in:8080/xmlui/handle/20.500.12252/2305.

Full text
APA, Harvard, Vancouver, ISO, and other styles
45

McCallum, Emma Clare. "Adaptive phase II clinical trial design using nonlinear dose-response models." Thesis, University of Cambridge, 2015. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.709013.

Full text
APA, Harvard, Vancouver, ISO, and other styles
46

Silal, Sheetal Prakash. "A simulation model of antimalarial drug resistance." Master's thesis, University of Cape Town, 2009. http://hdl.handle.net/11427/9003.

Full text
Abstract:
Includes bibliographical references (leaves 132-137).<br>Malaria ranks among the world's most important tropical parasitic diseases with world prevalence figures between 350 and 550 million clinical cases per annum. [WHO, 2008a] 'Treatment and prevention of malaria places a considerable burden on struggling economies where the disease is rampant. Research in malaria does not stop as the change in response to antimalarial drug treatment requires the development of new drugs and innovation in the use of old drugs. This thesis focused on building a model of the spread of resistance to Sulfadoxine
APA, Harvard, Vancouver, ISO, and other styles
47

Cereto, Massagué Adrià. "Development of tools for in silico drug discovery." Doctoral thesis, Universitat Rovira i Virgili, 2017. http://hdl.handle.net/10803/454678.

Full text
Abstract:
El cribratge virtual és un mètode quimioinformàtic que consisteix en cribrar molècules bioactives de grans bases de dades de molècules petites. Això permet als investigadors d’estalviar-se el cost de provar experimentalment cents o milers de compostos candidats, reduïnt-ne el nombre fins a quantitats manejables. Per a la validació dels mètodes de cribratge virtual calen biblioteques de molècules cimbell. El programari DecoyFinder fou desenvolupat com a aplicació gràfica de fàcil ús per a la construcció de biblioteques de molècules cimbell, i fou posteriorment ampliat amb les troballes de recer
APA, Harvard, Vancouver, ISO, and other styles
48

Zong, Jingyi. "The development of anti-cancer drug delivery systems." Thesis, Durham University, 2016. http://etheses.dur.ac.uk/11927/.

Full text
Abstract:
Cancer is undoubtedly one of the main threats to global human health and as a result, despite significant advances in the field, new and improved cancer treatments are still in great need. Although chemotherapy (in combination with other therapies) is widely used to suppress the growth of tumours, many of the current anti-cancer drugs suffer from poor selectivity and consequently severe toxicity. In order to conquer these limitations, targeted drug delivery systems have been designed and studied with the primary aim of improving the accuracy of transporting anti-cancer drugs into cancer cells
APA, Harvard, Vancouver, ISO, and other styles
49

Acoca, Stephane. "In silico methods in drug discovery and development." Thesis, McGill University, 2012. http://digitool.Library.McGill.CA:80/R/?func=dbin-jump-full&object_id=110376.

Full text
Abstract:
Computational drug design methods have become increasingly invaluable in the drug discovery and development process. Throughout this thesis will be described the development and application of methods that are used at every stage of the drug discovery and development pipeline. In Chapter 2 will take a look at the use computational methods towards the understanding and development of two novel Bcl-2 inhibitors, Obatoclax and ABT-737, being developed for the treatment of Cancer. The study proposes certain mechanisms through which ABT-737 displays selectivity towards certain targets within the Bc
APA, Harvard, Vancouver, ISO, and other styles
50

Saovapakhiran, Angkana. "Development of novel dendrimer carriers for drug delivery." Thesis, University of Reading, 2008. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.492737.

Full text
Abstract:
Polyamidoamine (PAMAM) dendrimers represent a novel type of polymer with numerous pharmaceutical applications and have been en investigated as transcellular carriers. However, the mechanisms of cellular uptake and intracellular processing of dendrimers are not fully understood. In this study the mechanism of cellular uptake of PAMAM dendrimer and surface-modified PAMAM dendrimers was investigated in order to optimise dendrimers as potential drug carriers.
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the bibliographies on the topic 'Drug development' for other source types:
Journal articles Books
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography